Cargando…
Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea
The aim of the study was to investigate the genetic and immunogenic features of commercial vaccines against infectious bronchitis virus (IBV), which is a major contagious pathogen of poultry. Although numerous vaccines have been developed based on the genetic characteristics of field strains, the co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272870/ https://www.ncbi.nlm.nih.gov/pubmed/35816229 http://dx.doi.org/10.1007/s00705-022-05519-2 |
_version_ | 1784744961503133696 |
---|---|
author | Jung, Ji Seung Lee, Rangyeon Yoon, Sung-il Lee, Geun-Shik Sung, Haan Woo Kwon, Hyuk Moo Park, Jeongho |
author_facet | Jung, Ji Seung Lee, Rangyeon Yoon, Sung-il Lee, Geun-Shik Sung, Haan Woo Kwon, Hyuk Moo Park, Jeongho |
author_sort | Jung, Ji Seung |
collection | PubMed |
description | The aim of the study was to investigate the genetic and immunogenic features of commercial vaccines against infectious bronchitis virus (IBV), which is a major contagious pathogen of poultry. Although numerous vaccines have been developed based on the genetic characteristics of field strains, the continual emergence of variants decreases vaccine efficacy and cross-protection. To address this issue, we compared the S1 gene sequences of three IBV vaccines commercially available in Korea with those of various field isolates. Phylogenetic analysis showed that the vaccine strains clustered into two different lineages. Comparison of commercial vaccines with their parental viruses showed that most of the genetic variability occurred around hypervariable regions (HVRs). Conversely, antigenic stimulation with commercial vaccines and regional IBV variants was not sufficient to alter major immune cell phenotypes. Our study suggests that vaccines should be selected carefully based on their genetic background because genetic variability can affect the antigenicity of vaccines and host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00705-022-05519-2. |
format | Online Article Text |
id | pubmed-9272870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-92728702022-07-11 Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea Jung, Ji Seung Lee, Rangyeon Yoon, Sung-il Lee, Geun-Shik Sung, Haan Woo Kwon, Hyuk Moo Park, Jeongho Arch Virol Original Article The aim of the study was to investigate the genetic and immunogenic features of commercial vaccines against infectious bronchitis virus (IBV), which is a major contagious pathogen of poultry. Although numerous vaccines have been developed based on the genetic characteristics of field strains, the continual emergence of variants decreases vaccine efficacy and cross-protection. To address this issue, we compared the S1 gene sequences of three IBV vaccines commercially available in Korea with those of various field isolates. Phylogenetic analysis showed that the vaccine strains clustered into two different lineages. Comparison of commercial vaccines with their parental viruses showed that most of the genetic variability occurred around hypervariable regions (HVRs). Conversely, antigenic stimulation with commercial vaccines and regional IBV variants was not sufficient to alter major immune cell phenotypes. Our study suggests that vaccines should be selected carefully based on their genetic background because genetic variability can affect the antigenicity of vaccines and host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00705-022-05519-2. Springer Vienna 2022-07-11 2022 /pmc/articles/PMC9272870/ /pubmed/35816229 http://dx.doi.org/10.1007/s00705-022-05519-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Jung, Ji Seung Lee, Rangyeon Yoon, Sung-il Lee, Geun-Shik Sung, Haan Woo Kwon, Hyuk Moo Park, Jeongho Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea |
title | Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea |
title_full | Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea |
title_fullStr | Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea |
title_full_unstemmed | Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea |
title_short | Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea |
title_sort | genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in korea |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272870/ https://www.ncbi.nlm.nih.gov/pubmed/35816229 http://dx.doi.org/10.1007/s00705-022-05519-2 |
work_keys_str_mv | AT jungjiseung geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea AT leerangyeon geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea AT yoonsungil geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea AT leegeunshik geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea AT sunghaanwoo geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea AT kwonhyukmoo geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea AT parkjeongho geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea |